Mallinckrodt plc invests €45 million to expand its operations in Dublin, Ireland

Specifications:

Name:

Mallinckrodt plc invests €45 million to expand its operations in Dublin, Ireland

Location:

Dublin, Ireland

Company:

Mallinckrodt plc

Estimated Cost:

€45 million

Source:

mallinckrodt.com 

Introduction:

Mallinckrodt plc, a leading global specialty biopharmaceutical company, announced a €45million investment to expand its Dublin-based operations.

Features:

This Expansion includes a new state-of-the-art manufacturing facility and office building are to be located at College Business and Technology Park, Blanchardstown, Dublin 15. The development will provide 300 jobs during the two-year construction phase and 45 skilled full-time positions once the construction is completed.

The new state-of-the-art facility will include a two-storey manufacturing building, a three-storey administration building and additional areas for future investment on a c.4.85 hectare site.

This significant capital investment brings Mallinckrodt Pharmaceuticals’ investment in Ireland to more than €165million over the past 22 years. The company provides treatment options for patients with a wide variety of health conditions, with a particular focus on autoimmune and rare diseases, analgesia, neonatal critical care respiratory therapies, and central nervous system disorders. Mallinckrodt employs more than 120 people at its existing manufacturing site and offices in Dublin.